Canada Pen Needles Market (2024-2029)
The Canada Pen Needles Market was valued at $37.82 Million in 2024 and projected to reach to $54.27 Million by 2029, representing a compound annual growth rate of 6.2%. Canada's pen needles market is positioned for consistent growth through 2029, supported by increasing diabetes diagnoses and the shift toward patient-centric injectable delivery systems.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Canada Pen Needles Market Trends and Insights
- This 6.2% compound annual growth rate reflects increasing adoption of injectable diabetes management therapies across Canada, driven by rising prevalence of type 1 and type 2 diabetes.
- Canada's healthcare infrastructure and patient access to insulin delivery devices support sustained demand for pen needles throughout the forecast period. The Canadian market benefits from strong reimbursement policies and growing awareness of diabetes management among healthcare providers and patients.
- Canada's aging population and lifestyle factors contribute to higher diabetes incidence, directly increasing pen needle consumption.
- Market expansion in Canada is supported by both public healthcare coverage and private insurance plans that recognize the importance of reliable injection devices for optimal therapeutic outcomes..
Key Market Statistics
- CAGR (2024-2029) 6.2% CAGR
- Market Size, 2024 ~USD 37.82 Million
- Forecast, 2029 ~USD 54.27 Million
- Country Canada
Canada Pen Needles Market Overview
Market Size & Growth :
Canada's pen needles market reached $37.82 million in 2024 and is projected to grow to $54.27 million by 2029, representing a steady 6.2% CAGR, outpacing many developed markets in adoption rates.
Diabetes Prevalence Driver :
Rising incidence of type 1 and type 2 diabetes across Canada is fueling demand for injectable therapies, with pen needles becoming the preferred delivery method among Canadian patients and healthcare providers.
Healthcare Infrastructure Advantage :
Canada's robust public healthcare system and universal coverage ensure consistent patient access to insulin and injectable medications, supporting sustained market expansion and product adoption.
Regional Growth Differential :
Canada's 6.2% CAGR is lower than the global average of 9.2%, indicating a mature market with established penetration but continued opportunities in underserved regions and patient segments.
Canada Pen Needles Market Dynamics
- The Canadian healthcare system's emphasis on preventive care and medication accessibility creates a favorable environment for pen needle adoption among both type 1 and type 2 diabetic populations.
- Expanding awareness campaigns and improved reimbursement policies are expected to drive market penetration in secondary and tertiary care settings. Looking ahead, technological innovations in needle design and gauge optimization will enhance patient comfort and compliance rates across Canada.
- Partnerships between pharmaceutical manufacturers and Canadian healthcare providers will strengthen distribution channels, while growing emphasis on diabetes management education will support market expansion.
- The market's steady 6.2% growth trajectory reflects Canada's mature healthcare landscape with sustained demand for reliable, convenient injection solutions..
Related Ecosystem
Drug Delivery Devices
- Disposable Autoinjectors
- Reusable Autoinjectors
- Insulin Pumps
- Pen Injectors
- Transdermal Patches
- Novo nordisk a/s
- Becton, Dickinson and Company
- Terumo Corporation
- Medtronic plc
- Nipro Corporation
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Canada's pen needles market is valued at $37.82 million in 2024 and will reach $54.27 million by 2029, representing a 6.2% CAGR.
- Rising diabetes prevalence in Canada drives consistent demand for injectable therapies and associated pen needle products.
- Canada's robust healthcare reimbursement system and public coverage support market accessibility and patient adoption.
- Aging demographics and lifestyle factors in Canada contribute to sustained long-term growth in pen needle consumption.
Pen Needles Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | SAFETY PEN NEEDLES (Type) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 9.2% from 2024 to 2029 |
| Largest Segment | STANDARD PEN NEEDLES (Type) |
| Market Size Base Year (Billions) | ~USD 1.82 (2024) |
| Revenue Forecast (Billions) | ~USD 3.08 (2029) |
| Segments Covered | Type, Length, Application, Mode Of Purchase, Care Setting |
Canada Pen Needles Market Report Segmentation
5 segment dimensions are covered across the global market.
By Type
- Safety Pen Needles
- Standard Pen Needles
By Length
- 10Mm
- 12Mm
- 4Mm
- 5Mm
- 6Mm
- 8Mm
By Application
- Glp-1 Therapy
- Growth Hormone Therapy
- Insulin Therapy
- Osteoporosis
- Other Applications
By Mode Of Purchase
- Online Purchase
- Otc Purchase
- Other Modes Of Purchase
- Prescription-Based Purchase
By Care Setting
- Home Care Settings
- Hospitals & Clinics
- Hospitals And Clinics
- Other End Users
CANADA: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| GLP-1 THERAPY | 2.56 | 2.6 | 2.7 | 2.84 | 3 | 3.37 | 3.59 | 3.84 | 6.1 |
| GROWTH HORMONE THERAPY | 0.81 | 0.79 | 0.79 | 0.8 | 0.81 | 0.85 | 0.87 | 0.89 | 2 |
| INSULIN THERAPY | 33.36 | 34.16 | 35.88 | 38.14 | 40.65 | 46.59 | 50.12 | 54.11 | 7.1 |
| OSTEOPOROSIS | 2.06 | 2.08 | 2.16 | 2.26 | 2.38 | 2.65 | 2.81 | 2.99 | 5.6 |
| OTHER APPLICATIONS | 3.5 | 3.48 | 3.54 | 3.66 | 3.78 | 4.08 | 4.26 | 4.47 | 3.9 |
| TOTAL | 42.29 | 43.11 | 45.06 | 47.7 | 50.62 | 57.53 | 61.65 | 66.3 | 6.6 |
Target Audience
- Medical Device Manufacturers : Manufacturers need Canada-specific market data to develop localized product strategies, optimize pricing for provincial healthcare systems, and identify distribution partnerships in this $37.82M market.
- Pharmaceutical Companies : Pharma firms require insights into Canadian diabetes patient populations and pen needle adoption rates to align insulin product launches with appropriate delivery device strategies and reimbursement pathways.
- Healthcare Investors & PE Firms : Investors need detailed Canadian market forecasts and growth drivers to evaluate acquisition targets, assess portfolio company performance, and identify emerging opportunities in the diabetes care sector.
- Healthcare Distributors & Retailers : Distributors require Canada market intelligence to optimize inventory management, negotiate supplier contracts, and identify high-growth regions within provincial healthcare networks.
- Government & Policy Makers : Canadian health authorities and policymakers need market data to inform diabetes management guidelines, evaluate healthcare spending efficiency, and ensure equitable access to injection devices across provinces.
Key Companies in the Canada Pen Needles Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Injectable and infusion-based delivery in LTAC hospitals,Oral drug administration in inpatient rehabilitation facilities,Contract rehabilitation and outpatient-related drug administration support, |
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automated manufacturing and assembly systems,Lifecycle services and digital/connected factory solutions,Contract manufacturing and value-added integration, |
| ALLERGAN PLC | Ireland | Private Company | Medical Aesthetics & Dermatology,Eye Care,Neuroscience & CNS, |
| CONSORT MEDICAL | United Kingdom | Private Company | Inhalation delivery devices,Injectable and autoinjector devices,Nasal and other specialty devices, |
| HENRY SCHEIN | United States | Public Company | Global Distribution & Value-Added Services,Global Specialty Products,Global Technology, |
| EMBECTA CORP. | United States | Public Company | Pen needles,Syringes,Safety injection devices, |
| NOVO NORDISK A/S | Denmark | Public Company | GLP-1 for Diabetes (injectable and oral),Obesity Care (GLP-1, including Wegovy pill),Insulin and Smart Pens (NovoPen 6, Echo Plus, needles), |
| YPSOMED | Switzerland | Public Company | Pen injectors,Auto-injectors,Wearable injectors and patch pumps, |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
| NIPRO | Japan | Public Company | Dialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products,Pharmaceutical-related (generics, kits, CDMO for injectables and oral drugs), |
| ARKRAY, INC. | Japan | Private Company | Diabetes testing & blood glucose monitoring,Urinalysis,Immunodiagnostics, |
| HTL-STREFA | Poland | Private Company | Safety lancets for professional capillary sampling,Personal lancets for home blood glucose monitoring,Pen needles for diabetes therapy, |
| BERPU MEDICAL TECHNOLOGY CO., LTD. | China | Private Company | Regular insulin pen needles,Safety insulin pen needles and pens,Hypodermic and hypo-dermal needles, |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates with 64,200 employees. The company provides healthcare services and related solutions across the United States.
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc. is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ALLERGAN PLC
Allergan PLC is an Ireland-based private company founded in 1983 with 17,400 employees. The company operates in the pharmaceutical and medical aesthetics sectors.
CONSORT MEDICAL
Consort Medical is a United Kingdom-based private company founded in 1938 with 2,000 employees. The company provides medical device and pharmaceutical delivery solutions.
HENRY SCHEIN
Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a distributor of healthcare products and services to medical, dental, and veterinary professionals.
EMBECTA CORP.
Embecta Corp. is a United States-based public company founded in 1924 with 1,850 employees. The company manufactures and distributes diabetes care and medical devices.
NOVO NORDISK A/S
Novo Nordisk A/S is a Denmark-based public company founded in 1923 with 67,900 employees. The company is a global pharmaceutical company specializing in diabetes, obesity, and other chronic diseases.
YPSOMED
Ypsomed is a Switzerland-based public company founded in 1984 with 2,025 employees. The company develops and manufactures injection and infusion systems for diabetes and other therapeutic areas.
TERUMO CORPORATION
Terumo Corporation is a Japan-based public company founded in 1921 with 30,591 employees. The company manufactures and distributes medical devices, blood products, and pharmaceutical solutions globally.
NIPRO
Nipro is a Japan-based public company founded in 1947 with 38,593 employees. The company manufactures and supplies medical devices, pharmaceuticals, and healthcare products worldwide.
ARKRAY, INC.
Arkray, Inc. is a Japan-based private company founded in 1960 with 566 employees. The company manufactures diagnostic and medical devices for healthcare applications.
HTL-STREFA
HTL-Strefa is a Poland-based private company founded in 2000. The company manufactures medical devices and related healthcare products.
BERPU MEDICAL TECHNOLOGY CO., LTD.
Berpu Medical Technology Co., Ltd. is a China-based private company founded in 2000. The company manufactures medical devices and related healthcare solutions.
Reasons to Buy this Report
- Canada-Specific Market Sizing : Access precise market valuations for Canada ($37.82M in 2024) with detailed 5-year forecasts, enabling accurate budget allocation and revenue projections for Canadian operations.
- Competitive Landscape Intelligence : Understand market dynamics specific to Canada's healthcare system, including key players, distribution channels, and reimbursement structures unique to the Canadian market.
- Growth Driver Analysis : Identify diabetes prevalence trends, patient demographics, and healthcare infrastructure factors driving the 6.2% CAGR in Canada, informing targeted market entry and expansion strategies.
- Regulatory & Reimbursement Insights : Gain clarity on Canadian regulatory requirements, provincial healthcare coverage policies, and reimbursement frameworks affecting pen needle market accessibility and profitability.
- Strategic Investment Guidance : Make informed decisions on market entry timing, product positioning, and partnership opportunities in Canada's stable, mature healthcare market with predictable growth patterns.
Frequently asked questions
What is the current size of Canada's pen needles market?
Canada's pen needles market was valued at $37.82 million in 2024 and is expected to grow to $54.27 million by 2029.
What is the projected growth rate for pen needles in Canada?
Canada's pen needles market is projected to grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2029.
What factors are driving growth in Canada's pen needles market?
Key drivers include rising diabetes prevalence, an aging population, strong healthcare reimbursement policies, and increased patient awareness of injectable diabetes management in Canada.
How does Canada's healthcare system support pen needle market growth?
Canada's public healthcare coverage and private insurance plans provide broad reimbursement for insulin delivery devices, ensuring patient access and consistent demand for pen needles.
What is the forecast market value for pen needles in Canada by 2029?
Canada's pen needles market is forecasted to reach $54.27 million by 2029, up from $37.82 million in 2024.
RESEARCH METHODOLOGY
This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the pen needles market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply side and demand side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the pen needles market. Primary sources from the demand side included hospitals, clinics, researchers, lab technicians, purchase managers etc, and stakeholders in corporate & government bodies.
A breakdown of the primary respondents for pen needles market (supply side) market is provided below:
Note 1: Companies are classified into tiers based on their total revenue. As of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
Note 2: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 3: Other primaries include sales managers, marketing managers, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size for pen needles market was calculated using data from four different sources, as will be discussed below. Each technique concluded and a weighted average of the four ways was calculated based on the number of assumptions each approach made. The market size for pen needles market was calculated using data from three distinct sources, as will be discussed below:
Data Triangulation
The entire market was split up into five segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at the precise statistics for all segments.
Approach to derive the market size and estimate market growth.
Using secondary data from both paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of pen needles. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
A pen needle is a hollow needle entrenched in a plastic hub and attached to injectable pens. Pen needles are available in a wide range of lengths and diameters and can be used by healthcare professionals and patients to deliver injectable medications into the patient’s body. Pen needles are electro-polished for smooth, thin, and fine-point tips and provide comfort and ease in penetration; they serve as an alternative drug delivery technique to the traditional method of injecting drugs.
Stakeholders
- Manufacturers of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
- Original equipment manufacturing companies
- Suppliers and distributors of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
- Healthcare service providers
- Teaching hospitals and academic medical centers
- Health insurance players
- Government bodies/municipal corporations
- Regulatory bodies
- Business research and consulting service providers
- Authorities framing reimbursement policies for pen needles
- Venture capitalists
- Market research and consulting firms
Report Objectives
- To define, describe, and forecast the pen needles market based on type, length, application, mode of purchase, setting and region.
- To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall pen needles market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the pen needles market in North America, Europe, the Asia Pacific, Latin America, Middle East & Africa and GCC Countries
- To profile the key players and comprehensively analyze their market shares and core competencies in the pen needles market
- To track and analyze competitive developments such as partnerships, expansions, acquisitions, collaborations, product launches, agreements, and other developments in the pen needles market
- To benchmark players within the pen needles market using the Company Evaluation Quadrant framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings.
Get the Full Pen Needles Market Report
Full forecast, segment splits, and company analysis for all Pen Needles Market.
- US Pen Needles Market
- Germany Pen Needles Market
- UK Pen Needles Market
- France Pen Needles Market
- Italy Pen Needles Market
- Spain Pen Needles Market
- Japan Pen Needles Market
- China Pen Needles Market
- India Pen Needles Market
- South Korea Pen Needles Market
- Brazil Pen Needles Market
- Mexico Pen Needles Market
- Argentina Pen Needles Market
- GCC Countries Pen Needles Market
- Rest Of Europe Pen Needles Market
- Rest Of Asia Pacific Pen Needles Market
- Southeast Asia Pen Needles Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
